Evidence mapPaperPMID 39836696Full record

ArticlePLOS global public health2025

Perceptions of diabetic retinopathy patients on the management of diabetic retinopathy (DR) in South Tarawa, Kiribati: A qualitative study.

Teuota Angirerei-Farran, Masoud Mohammadnezhad, Kal Alnababatah, Mosese Salusalu

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Teuota Angirerei-FarranDepartment of Public Health, Ministry of Health & Medical Services, Nawerewere, Tarawa, Kiribati.ORCID https://orcid.org/0009-0002-8451-0616
Masoud MohammadnezhadSchool of Nursing and Midwifery, Birmingham City University, Birmingham, United Kingdom.ORCID https://orcid.org/0000-0002-5048-9719
Kal AlnababatahSchool of Nursing and Midwifery, Birmingham City University, Birmingham, United Kingdom.
Mosese SalusaluSchool of Public Health and Primary Care, Fiji National University, Suva, Fiji.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic Retinopathy (DR) is one of the most common causes of legal blindness in developing countries, particularly between the ages of 20 to 65 years. Kiribati is currently facing the burden of DR where more than 5% of diabetes patients had experienced negative impacts of DR. This study aimed to explore the perceptions of DR patients on DR management in South Tarawa, Kiribati. This qualitative study was carried out at the Eye clinic in Tarawa Central Hospital from the 29th of August to 23rd of September, 2022. Patients diagnosed with DR of both sexes aged ≥ 18 years were purposively selected to participate in this study. 27 DR patients were recruited and interviewed using a semi-structured open-ended questionnaire. Manual thematic analysis was applied to observe the similarities and differences in answers obtained from interview transcripts. A total of 27 DR patients were enrolled in this study. The majority of patients were between the age of 50-59 (37%) and were males (62%). The findings highlighted a lack of knowledge and awareness of DR management among patients with diabetes in Kiribati. Poor health education, in-availability and lack of access to eye care services, patient belief, and healthcare system issues were identified as the most crucial contributing barriers. These data characterized the need for more communication campaigns including specific messaging on DR and its management to increase diabetes patients' awareness of the importance of DR treatments.

Identifiers

PMID39836696
PMCPMC11750083

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.